I can understand the anxiety of many shareholders over seemingly many 'good' things happening and yet there is no 'concrete revenue' announcement and price is not moving.

If it helps to calm minds, I suggest we do not read all pr and blogs as though they are written for shareholders. If I were Gerald, my last focus will be the shareholders. My battle is with the big boys and focus is on business. At least that is what I will do for my company. Cruel reality but necessary for business survival.

For example, I read that Jason napodano has forecast a 1m revenue for lympro in 2015 and it seemingly has unsettled many shareholders here. The info is not meant for public shareholders. It may be for prospects who are potentially selling assets to ambs. Maybe because ambs has secured a deal with a partner on lympro, ambs may have changed the tune via Jason. Pure speculation but that's what I will do.

Hope that it calms some nerves here. Eventually it requires some faith in investment because public shareholders do not know maybe even 10% of what is truly happening behind the scenes. If one is not comfortable, sell his investment and move on.

It truly is a fierce battlefield in business. The last persons I care to inform are the public shareholders. Hard truth.